Delivery Order SPE2DR25D2104-SPE2DR26F3TYJ
- Not listed
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $11,576.96 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This firm fixed-price delivery order, which is not set aside for any specific business category, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026. The award represents a small task order under AmerisourceBergen's larger...
- On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $32,118.24 to Amerisourcebergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 16, 2026, and represents a non-set-aside competitive award. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,218.48 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, which is neither set-aside nor restricted to specific business categories, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. The award represents a task order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,921.19 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens on December 19, 2025, with completion targeted for December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small but critical pharmaceutical procurement supporting military and federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary...
- The Defense Logistics Agency awarded a $9,831.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens on January 20, 2026, with completion targeted for January 21, 2026. This non-set-aside delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (which does business as AmerisourceBergen), is a major pharmaceutical distributor...
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,652.23 to Amerisourcebergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. The contract carries a firm fixed-price structure with an ultimate completion date of January 12, 2026, and was awarded on a competitive, non-set-aside basis. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical...
- The Defense Logistics Agency awarded a $10,541.01 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector pens. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in...
- On January 9, 2026, the Defense Logistics Agency awarded a $37,342.01 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with performance through January 12, 2026. The contract utilizes firm fixed-price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company Cencora, Inc. (doing business as AmerisourceBergen)...
- The Defense Logistics Agency awarded a $69,558.28 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 31, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers....
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TYJDelivery Order
On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $7,572.61 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick autoinjector pens. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Repatha is a prescription medication used for cholesterol management, and this delivery order represents a routine fulfillment under the broader pharmaceutical prime vendor arrangement supporting Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 1/19/26 |